Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Nuclear Medicine

Free Subscription Articles published in Semin Nucl Med Retrieve available abstracts of 195 articles: HTML format

Single Articles

October 2026
1. SADEGHPOUR S, Mirshahvalad SA, Askari E, Doostparast A, et al
   Fibroblast activation protein-targeted PET uptake across various histopathological and molecular subtypes of breast cancer: a systematic review and meta-analysis.
   Semin Nucl Med. 2026 Oct 29:S0001-2998(26)00193.
   PubMed     Abstract available
   
   
   
2. VAN SCHAIK L, Huisman SA, Appelman-Dijkstra NM, de Geus-Oei LF, et al
   Diagnostic accuracy and clinical value of quantitative Na[(18)F]F PET/CT parameters to monitor therapeutic response in patients with benign metabolic bone diseases: A systematic review.
   Semin Nucl Med. 2026 Oct 28:S0001-2998(26)00188.
   PubMed     Abstract available
   
   
   
3. BECKER S, Tually P, Currie GM
   Companion animal nuclear medicine: A translational evidence map for dogs and cats.
   Semin Nucl Med. 2026 Oct 28:S0001-2998(26)00191.
   PubMed     Abstract available
   
   
   
4. IMPERIALE A, Mouissi I, Huon M, Taieb D, et al
   Normal variants, pitfalls, and interpretation challenges of somatostatin receptor PET.
   Semin Nucl Med. 2026 Oct 24:S0001-2998(26)00189.
   PubMed     Abstract available
   
   
   
5. BULTEN BF, van der Bruggen W
   PET/CT in benign bone disorders: An update.
   Semin Nucl Med. 2026 Oct 6:S0001-2998(26)00185.
   PubMed     Abstract available
   
   
   September 2026
6. METRARD G, Mazet R, Bailly M
   Parametric dynamic SPECT using a 3D CZT-ring camera for rapid characterization of disseminated splenosis.
   Semin Nucl Med. 2026 Sep 18:S0001-2998(26)00179.
   PubMed     Abstract available
   
   
   
7. TORRICELLI C, Nogueira-Lima E, Etchebehere E
   The value of (18)F-fluoride PET in bone metastases: an overview.
   Semin Nucl Med. 2026 Sep 17:S0001-2998(26)00181.
   PubMed     Abstract available
   
   
   
8. ERYILMAZ Y, Gezmis E, Uner A, Akin S, et al
   MALT lymphoma with synchronous lacrimal gland and gastric involvement on (18)F-FDG PET/CT: a rare presentation.
   Semin Nucl Med. 2026 Sep 12:S0001-2998(26)00180.
   PubMed     Abstract available
   
   
   
9. HLONGWA K, Brink A, More S
   Paediatric nephro-urology imaging: updates in renal scintigraphy and pitfalls.
   Semin Nucl Med. 2026;56:825-838.
   PubMed     Abstract available
   
   
   
10. VALI R, Shammas A, Kwatra N, Jenabihaghparast E, et al
    Pediatric gastrointestinal transit scintigraphy: From esophageal transit to whole-gut transit.
    Semin Nucl Med. 2026;56:860-875.
    PubMed     Abstract available
    
    
    August 2026
11. DIETZE A, Aebersold DM, Rominger A, Lapa C, et al
    FAPI PET in musculoskeletal oncology: An update and future directions.
    Semin Nucl Med. 2026 Aug 27:S0001-2998(26)00164.
    PubMed     Abstract available
    
    
    
12. MASOOD S, McKinnon NK, States LJ, Zuckier LS, et al
    Update on nuclear medicine in end-of-life care of infants and children: radionuclide perfusion studies in the determination of death by neurological criteria (DNC).
    Semin Nucl Med. 2026 Aug 24:S0001-2998(26)00162.
    PubMed     Abstract available
    
    
    
13. VAN DE WIELE C, Sathekge C, Maes J, Li S, et al
    Preparation of children for nuclear medicine examinations: A chronological, multi-modal approach to sedationless care.
    Semin Nucl Med. 2026 Aug 24:S0001-2998(26)00165.
    PubMed     Abstract available
    
    
    
14. AL-HOUWARI RM, Al-Qasem S, Moghrabi S, Ashour L, et al
    PET/CT in acute and time-sensitive non-oncological conditions: Current evidence, clinical applications, and emerging roles.
    Semin Nucl Med. 2026 Aug 24:S0001-2998(26)00158.
    PubMed     Abstract available
    
    
    
15. CURRIE GM, Bailey DL
    The innovation logic cycle of nuclear medicine: Translation, adoption, and reinvention across 130 years.
    Semin Nucl Med. 2026 Aug 17:S0001-2998(26)00156.
    PubMed     Abstract available
    
    
    
16. AYENI A, Tebeila T, Jonas M, Evbuomwan O, et al
    PET/CT In paediatric lymphoma: Current role and advances.
    Semin Nucl Med. 2026 Aug 14:S0001-2998(26)00151.
    PubMed     Abstract available
    
    
    
17. PURANIK AD
    Neuroblastoma imaging: From MIBG to advanced PET tracers.
    Semin Nucl Med. 2026 Aug 7:S0001-2998(26)00146.
    PubMed     Abstract available
    
    
    
18. KAGHAZCHI F, Vali R, Shammas A
    Update on pediatric nuclear medicine in acute care.
    Semin Nucl Med. 2026 Aug 6:S0001-2998(26)00148.
    PubMed     Abstract available
    
    
    
19. WONDERGEM M, van der Zant FM, Meijer-Jorna LB, Bos SD, et al
    Detection of an inflammatory myofibroblastic tumor in the testis by FDG-PET/CT; a rare presentation of a rare neoplasm.
    Semin Nucl Med. 2026 Aug 6:S0001-2998(26)00145.
    PubMed     Abstract available
    
    
    
20. METRARD G, Cohen C, Le Rouzic G, Bailly M, et al
    From static to dynamic SPECT/CT: A systematic review of clinical applications and perspectives.
    Semin Nucl Med. 2026 Aug 6:S0001-2998(26)00149.
    PubMed     Abstract available
    
    
    
21. MOGHRABI S, Ramonaheng K, Al-Houwari RM, Mohamedkhair A, et al
    Radiation dose optimization and dosimetry in pediatric nuclear medicine: Current concepts and future directions.
    Semin Nucl Med. 2026 Aug 5:S0001-2998(26)00142.
    PubMed     Abstract available
    
    
    July 2026
22. DEMIRTAS SENLIK S, Yilmaztekin B, Erol A, Demirel BB, et al
    Rare subcutaneous metastases of papillary thyroid carcinoma revealed by (18)F-FDG PET/CT.
    Semin Nucl Med. 2026 Jul 30:S0001-2998(26)00144.
    PubMed     Abstract available
    
    
    
23. TUALLY P, Becker S, Currie GM
    Equine nuclear medicine: Current state of play.
    Semin Nucl Med. 2026 Jul 29:S0001-2998(26)00143.
    PubMed     Abstract available
    
    
    
24. PANT V, Malasani V, Dash S, Nagaraj C, et al
    Nuclear medicine in paediatric tumours: current status and focus on theranostics.
    Semin Nucl Med. 2026 Jul 23:S0001-2998(26)00141.
    PubMed     Abstract available
    
    
    
25. CURRIE GM, Rohren EM
    Can AI Make Paediatric PET/CT Lower Dose? Opportunities, Evidence and Cautions.
    Semin Nucl Med. 2026 Jul 21:S0001-2998(26)00140.
    PubMed     Abstract available
    
    
    
26. AGRAWAL A, Gnanasegran G, Agrawal K, Kulkarni P, et al
    PET/CT Normal Variants and Pitfalls in Paediatric Disorders.
    Semin Nucl Med. 2026 Jul 17:S0001-2998(26)00139.
    PubMed     Abstract available
    
    
    
27. SADEGHPOUR S, Aghaee A, Doostparast A, Rezaei N, et al
    FAPI PET-guided tumor volume delineation for radiotherapy planning: A comprehensive review across solid tumors.
    Semin Nucl Med. 2026 Jul 15:S0001-2998(26)00138.
    PubMed     Abstract available
    
    
    
28. BOUCHELOUCHE K, Sathekge MM
    Expanding Horizons: The Role of Kaleidoscope and Relevant Images in Seminars in Nuclear Medicine.
    Semin Nucl Med. 2026;56:567-568.
    PubMed    
    
    
    June 2026
29. THOSTRUP AH, Stubbe NU, Schreiner MP, Bentestuen M, et al
    The diagnostic performance and clinical value of [18F]FDG PET/CT in pleural mesothelioma - A systematic review and meta-analysis.
    Semin Nucl Med. 2026 Jun 10:S0001-2998(26)00121.
    PubMed     Abstract available
    
    
    
30. SADEGHPOUR S, Saidi B, Sahafi P, Maleki F, et al
    Maximizing diagnostic yield: A systematic review and deep dive into PSMA PET scan protocol variations for prostate cancer.
    Semin Nucl Med. 2026 Jun 2:S0001-2998(26)00112.
    PubMed     Abstract available
    
    
    
31. SOVANI B, Ravindra SG, Javidan C, Dehdashti F, et al
    (18)F-FDG -PET/CT in cardiac sarcoidosis: Diagnosis, therapy monitoring, and future directions.
    Semin Nucl Med. 2026 Jun 1:S0001-2998(26)00113.
    PubMed     Abstract available
    
    
    May 2026
32. AL-MALLAH MH
    The role of cardiac PET imaging in cardiac amyloidosis.
    Semin Nucl Med. 2026 May 30:S0001-2998(26)00118.
    PubMed     Abstract available
    
    
    
33. ROY A, Abikhzer G, Slart RHJA, Alberini JL, et al
    PET imaging of large-vessel vasculitis: advancements and future trends.
    Semin Nucl Med. 2026 May 26:S0001-2998(26)00094.
    PubMed     Abstract available
    
    
    
34. WOPPERER SB, Kronzer E, Ivare J, Taheri M, et al
    FDG PET for cardiac sarcoidosis: Protocol optimization, quantification, pitfalls, and multimodality imaging integration.
    Semin Nucl Med. 2026 May 21:S0001-2998(26)00093.
    PubMed     Abstract available
    
    
    
35. HAMMOUD DA
    Imaging of immunocompromised patients: focus on fungal-specific PET tracers.
    Semin Nucl Med. 2026 May 18:S0001-2998(26)00095.
    PubMed     Abstract available
    
    
    
36. DIAS AH, Fosbol MO, Ivashchenko OV, Andersen FL, et al
    Positron emission tomography imaging of inflammation and infection in children: an update.
    Semin Nucl Med. 2026 May 6:S0001-2998(26)00091.
    PubMed     Abstract available
    
    
    
37. LAWAL IO, Ankrah AO, Abubakar S, Ndlovu H, et al
    Updates on tuberculosis imaging.
    Semin Nucl Med. 2026;56:486-499.
    PubMed     Abstract available
    
    
    April 2026
38. BUND S, Stahle M, Massalha S, Wechalekar K, et al
    Advancements in PET imaging of inflammatory cardiac diseases.
    Semin Nucl Med. 2026 Apr 30:S0001-2998(26)00090.
    PubMed     Abstract available
    
    
    
39. LAURI C, Aarntzen E, Glaudemans AW, Levi J, et al
    Radiopharmaceuticals for imaging T-cells.
    Semin Nucl Med. 2026 Apr 27:S0001-2998(26)00050.
    PubMed     Abstract available
    
    
    
40. JENABI E, Hotta M, Atzinger A, Volkmann E, et al
    The Role of FAPI PET/CT in the Assessment of Inflammatory Diseases.
    Semin Nucl Med. 2026 Apr 22:S0001-2998(26)00085.
    PubMed     Abstract available
    
    
    
41. ARNON-SHELEG E, Keidar Z
    Optimizing PET/CT and SPECT/CT in infection imaging: Acquisition, interpretation, and pitfalls.
    Semin Nucl Med. 2026 Apr 21:S0001-2998(26)00079.
    PubMed     Abstract available
    
    
    
42. MARTINAGE N, Ledoult E, Baillet C, Huglo D, et al
    [(18)F]FDG PET/CT imaging in Polyarteritis Nodosa-spectrum vasculitis.
    Semin Nucl Med. 2026 Apr 20:S0001-2998(26)00086.
    PubMed     Abstract available
    
    
    
43. TREGLIA G, Rizzo A, Albano D
    New targets for PET imaging of inflammation.
    Semin Nucl Med. 2026 Apr 20:S0001-2998(26)00084.
    PubMed     Abstract available
    
    
    
44. ANKRAH AO, Lawal IIO, Ndlovu H, Sathekge MM, et al
    Current status on imaging invasive fungal infections with positron emission tomography.
    Semin Nucl Med. 2026 Apr 18:S0001-2998(26)00087.
    PubMed     Abstract available
    
    
    
45. BULTEN BF, Slart RHJA, Glaudemans AWJM, Hess S, et al
    Standardization of infection [(18)F]FDG-PET/CT imaging protocols and reporting criteria.
    Semin Nucl Med. 2026 Apr 11:S0001-2998(26)00081.
    PubMed     Abstract available
    
    
    
46. OZTEK MA, Shulkin BL, Parisi MT
    Pediatric infection imaging focusing on FDG PET/CT: Techniques, safety, and indications.
    Semin Nucl Med. 2026 Apr 8:S0001-2998(26)00082.
    PubMed     Abstract available
    
    
    
47. LIU B, Hendrikse E, van der Geest KSM, Brouwer E, et al
    PET imaging of polymyalgia rheumatica: update and future trends.
    Semin Nucl Med. 2026 Apr 7:S0001-2998(26)00077.
    PubMed     Abstract available
    
    
    
48. ALBANO D, Urso L, Treglia G, Bertagna F, et al
    The value of [(18)F]FDG PET/CT in fever of unknown origin (FUO): an update and future aspects.
    Semin Nucl Med. 2026 Apr 6:S0001-2998(26)00076.
    PubMed     Abstract available
    
    
    
49. DONNELLY R, Boyle N, McCarthy C, Murphy DJ, et al
    FDG PET in pulmonary sarcoidosis: An update and future aspects.
    Semin Nucl Med. 2026 Apr 4:S0001-2998(26)00075.
    PubMed     Abstract available
    
    
    
50. JAMAR F, van der Heijden WRP, van der Laken CJ, Beha N, et al
    PET/CT in inflammatory joint disorders: update and future trends.
    Semin Nucl Med. 2026 Apr 3:S0001-2998(26)00078.
    PubMed     Abstract available
    
    
    March 2026
51. GATON-RAMIREZ J, Slart RHJA, Gheysens O, Noriega-Alvarez E, et al
    The evolving role of nuclear medicine in osteomyelitis: A narrative review of current evidence and future horizons.
    Semin Nucl Med. 2026 Mar 30:S0001-2998(26)00062.
    PubMed     Abstract available
    
    
    
52. ORUNMUYI AT, Wang M, Rogeau A, Dickson J, et al
    Structured reading for Tau PET Imaging in Alzheimer's disease and related dementias.
    Semin Nucl Med. 2026 Mar 26:S0001-2998(26)00047.
    PubMed     Abstract available
    
    
    
53. BADARNA M, Andraous M, Keidar Z
    18F-FDG PET/CT in the evaluation of suspected infections following cardiothoracic surgical interventions.
    Semin Nucl Med. 2026 Mar 26:S0001-2998(26)00065.
    PubMed     Abstract available
    
    
    
54. GATON-RAMIREZ J, Noriega-Alvarez E
    The role of nuclear medicine in abdominopelvic infections.
    Semin Nucl Med. 2026 Mar 26:S0001-2998(26)00064.
    PubMed     Abstract available
    
    
    
55. CURRIE GM, Bailey DL
    Quantification, radiomics and artificial intelligence in infection imaging: Current status and future directions in nuclear medicine.
    Semin Nucl Med. 2026 Mar 12:S0001-2998(26)00044.
    PubMed     Abstract available
    
    
    
56. CURRIE GM
    Re-defining the 3Rs of pre-clinical research in nuclear medicine.
    Semin Nucl Med. 2026 Mar 12:S0001-2998(26)00043.
    PubMed     Abstract available
    
    
    
57. MENA E, Lindenberg L, Heng S, Choyke PL, et al
    Advances and challenges of PET imaging in bladder cancer-An update and future trends.
    Semin Nucl Med. 2026 Mar 2:S0001-2998(26)00046.
    PubMed     Abstract available
    
    
    
58. VALI R, Shammas A, Kwatra N, Haghparast EJ, et al
    Practical approach to diuretic renography in children: Techniques, interpretation, and pitfalls.
    Semin Nucl Med. 2026;56:258-277.
    PubMed     Abstract available
    
    
    
59. ZUCKIER LS
    Scintigraphy as an ancillary examination in determination of death by neurologic criteria: Update and future perspectives.
    Semin Nucl Med. 2026;56:354-363.
    PubMed     Abstract available
    
    
    
60. BRINK A, Bar-Sever Z, Orellana P, Pascual TN, et al
    Insights into the Global Practice of Paediatric Renal Scintigraphy Studies.
    Semin Nucl Med. 2026;56:235-243.
    PubMed     Abstract available
    
    
    
61. PETERS AM
    Renography: Methods and Pitfalls.
    Semin Nucl Med. 2026;56:244-257.
    PubMed     Abstract available
    
    
    
62. CURRIE GM, Rohren EM
    The Nuclear Nephrology Artificial Intelligence Ecosystem.
    Semin Nucl Med. 2026;56:313-328.
    PubMed     Abstract available
    
    
    
63. VOLKAN-SALANCI B
    Renal Scintigraphy in Adults: An Update.
    Semin Nucl Med. 2026;56:278-288.
    PubMed     Abstract available
    
    
    February 2026
64. MOKOALA KMG, Kaoma C, Jibril F, Kabunda J, et al
    Imaging of infection in Nephro-urology: A practical nuclear medicine-focused review.
    Semin Nucl Med. 2026 Feb 27:S0001-2998(26)00011.
    PubMed     Abstract available
    
    
    
65. PANDYA K, Lazar A, Serrano LL, Amon MC, et al
    Can FAPI-PET imaging address unmet needs in nephro-urology?
    Semin Nucl Med. 2026 Feb 6:S0001-2998(26)00001.
    PubMed     Abstract available
    
    
    January 2026
66. FUSO GA, Bianciardi G, Mei R, Brusa I, et al
    Retraction notice to Radiotracing the Future: Non-FDG Radiotracers Nuclear Medicine [Seminars Nucl Med 55 (2025) 648-663].
    Semin Nucl Med. 2026 Jan 16:S0001-2998(25)00185.
    PubMed    
    
    
    
67. VORSTER M, Sathekge M
    (18)F-FDG PET/CT for prediction of response in breast cancer.
    Semin Nucl Med. 2026 Jan 8:S0001-2998(25)00173.
    PubMed     Abstract available
    
    
    
68. SEN I, Malik D, Thakral P
    Clinical implementation of RECIP 1.0.
    Semin Nucl Med. 2026;56:5-8.
    PubMed     Abstract available
    
    
    
69. WIEFELS C, Juarez-Orozco LE, Craviolatti PS, Diahiliev O, et al
    Artificial intelligence in nuclear cardiology: Technical perspectives, strategic directions, and recommendations from an IAEA expert working group.
    Semin Nucl Med. 2026;56:119-131.
    PubMed     Abstract available
    
    
    
70. AGGARWAL P, Satapathy S, Chandekar KR, Sood A, et al
    Response Evaluation Criteria in Grade 1/2 Neuroendocrine Tumors (RECIN).
    Semin Nucl Med. 2026;56:22-30.
    PubMed     Abstract available
    
    
    December 2025
71. CIVAN C, Karpinski MJ, Rahbar K, Fendler WP, et al
    The value of PSMA PET for risk stratification in prostate cancer: an update and future aspects.
    Semin Nucl Med. 2025 Dec 25:S0001-2998(25)00181.
    PubMed     Abstract available
    
    
    
72. SHAGERA QA, Ozturk AA, Pabst KM, Longton E, et al
    FAPI PET imaging value in radiotherapy planning and assessment in head and neck cancers.
    Semin Nucl Med. 2025 Dec 17:S0001-2998(25)00174.
    PubMed     Abstract available
    
    
    
73. ARTESANI A, Olivieri M, Guglielmo P, Marenco M, et al
    PET-CT radiomics for immunotherapy response.
    Semin Nucl Med. 2025 Dec 13:S0001-2998(25)00176.
    PubMed     Abstract available
    
    
    
74. BENTESTUEN M, Dahlsgaard-Wallenius S, Stolberg MMK, Zacho HD, et al
    Nonmalignant findings on FAPI PET: An updated rapid systematic review of the literature.
    Semin Nucl Med. 2025 Dec 8:S0001-2998(25)00168.
    PubMed     Abstract available
    
    
    
75. SAFARIAN A, Muin D, Unterrainer L, Hormann A, et al
    The role of non-FDG agents in PET imaging of bladder cancer.
    Semin Nucl Med. 2025 Dec 8:S0001-2998(25)00165.
    PubMed     Abstract available
    
    
    
76. RIZZO A, Treglia G
    PSMA PET in renal cell carcinoma: an update and future aspects.
    Semin Nucl Med. 2025 Dec 3:S0001-2998(25)00166.
    PubMed     Abstract available
    
    
    
77. FILIPPI L, Mass ACL, Arslan E, Alcin G, et al
    Is There a Role of FAPI Pet in Renal and Bladder Cancer?
    Semin Nucl Med. 2025 Dec 1:S0001-2998(25)00157.
    PubMed     Abstract available
    
    
    
78. KATAYEU Y, Grunwald V, Pabst KM, Yesilyurt UU, et al
    New targets of PET imaging for renal cancer.
    Semin Nucl Med. 2025 Dec 1:S0001-2998(25)00159.
    PubMed     Abstract available
    
    
    November 2025
79. YANG R, Lu X, Tang W, Nardo L, et al
    Total-Body PET/CT Metabolic Response in Esophageal Squamous Cell Carcinoma.
    Semin Nucl Med. 2025 Nov 29:S0001-2998(25)00162.
    PubMed     Abstract available
    
    
    
80. UENO Y, Nogami M, Hirota K, Hyodo T, et al
    Any Role of FDG PET in Renal Cancer?
    Semin Nucl Med. 2025 Nov 29:S0001-2998(25)00158.
    PubMed     Abstract available
    
    
    
81. BADRANE I, Nieri A, Albano D, Arslan E, et al
    The Value of FDG PET/CT in Penile Cancer: An Update.
    Semin Nucl Med. 2025 Nov 29:S0001-2998(25)00160.
    PubMed     Abstract available
    
    
    
82. XIE Y, Deng Y, Cruz EB, Pradhan PK, et al
    Clinical Utility of FAPI PET/CT in Diagnosis, Staging, and Response Assessment of Colorectal Cancer.
    Semin Nucl Med. 2025 Nov 28:S0001-2998(25)00163.
    PubMed     Abstract available
    
    
    October 2025
83. HIGUCHI T, Chen X, Siegmund SC, Klimek K, et al
    Recent Advances and Future Trends of[(18)F]-Labeled PET Agents for Renal Imaging.
    Semin Nucl Med. 2025 Oct 15:S0001-2998(25)00124.
    PubMed     Abstract available
    
    
    September 2025
84. KABUNDA J, Ndlovu H, Singh K, Sibiya S, et al
    Nectin-4, Bladder Cancer, and Nuclear Medicine: A Theranostic Frontier.
    Semin Nucl Med. 2025 Sep 26:S0001-2998(25)00118.
    PubMed     Abstract available
    
    
    
85. THIENTUNYAKIT T, Muangpaisan W, Minoshima S
    Corrigendum to '18F-FDG PET for Dementia Evaluation: Co-pathologies, New Diseases, and Its Roles in The Era of Anti-Amyloid Treatment' [Seminar in Nuclear Medicine volume 55 (2025):526 -537/Article number YSNUC_51208].
    Semin Nucl Med. 2025 Sep 25:S0001-2998(25)00116.
    PubMed    
    
    
    July 2025
86. NYAKALE N, Maes A, Sathekge M, Li S, et al
    PSMA-Targeted Positron Emission Tomography Imaging in Solid Tumors Other Than Prostate Carcinoma: An Update.
    Semin Nucl Med. 2025 Jul 19:S0001-2998(25)00070.
    PubMed     Abstract available
    
    
    
87. SAFARIAN A, Mirshahvalad SA, Farbod A, Jung T, et al
    Artificial Intelligence for Tumor [(18)F]FDG PET Imaging: Advancements and Future Trends - Part II.
    Semin Nucl Med. 2025 Jul 18:S0001-2998(25)00086.
    PubMed     Abstract available
    
    
    
88. NOVRUZOV E, Mamlins E, Mori Y, Cardinale J, et al
    The Clinical Impact of FAPI PET Imaging: HCC, CCC, CUP & Peritoneal Carcinoma.
    Semin Nucl Med. 2025 Jul 18:S0001-2998(25)00090.
    PubMed     Abstract available
    
    
    
89. FUSO GA, Bianciardi G, Mei R, Brusa I, et al
    Radiotracing the Future: Non-FDG Radiotracers Nuclear Medicine.
    Semin Nucl Med. 2025 Jul 16:S0001-2998(25)00069.
    PubMed     Abstract available
    
    
    
90. PABST KM, Fendler WP, Jochheim LS, Herrmann K, et al
    The Value of FAPI PET/CT in Cholangiocarcinoma and Pancreatic Cancer: An Update.
    Semin Nucl Med. 2025 Jul 16:S0001-2998(25)00075.
    PubMed     Abstract available
    
    
    
91. LIN W, Huang C, Tan Z, Xu H, et al
    Cu(II)-bis(thioureido) Complex: A Potential Radiotracer for Detecting Oxidative Stress and Neuroinflammation in Neurodegenerative Diseases.
    Semin Nucl Med. 2025;55:577-586.
    PubMed     Abstract available
    
    
    
92. FILIPPI L, Schillaci O
    Global experience in brain amyloid imaging.
    Semin Nucl Med. 2025;55:538-547.
    PubMed     Abstract available
    
    
    June 2025
93. FERRANDO R, Hernandes D, Ghini BG, Coutinho AM, et al
    PET Imaging in Psychiatric Disorders.
    Semin Nucl Med. 2025 Jun 20:S0001-2998(25)00068.
    PubMed     Abstract available
    
    
    
94. RYU J, Oh M
    Positron Emission Tomography in Autism Spectrum Disorder: Current Status and Future Perspectives.
    Semin Nucl Med. 2025 Jun 12:S0001-2998(25)00065.
    PubMed     Abstract available
    
    
    
95. STORMEZAND GN, Doorduin J, Glaudemans AWJM, van der Hoorn A, et al
    Current Developments on [(18)F]FDG PET/CT in Inflammatory Disorders of the Central Nervous System.
    Semin Nucl Med. 2025 Jun 11:S0001-2998(25)00066.
    PubMed     Abstract available
    
    
    
96. YANG YJ, Zhao YX, Li XY, Zuo C, et al
    New Targets for Positron Emission Tomography Imaging in Parkinson s Disease.
    Semin Nucl Med. 2025 Jun 6:S0001-2998(25)00061.
    PubMed     Abstract available
    
    
    
97. DELGADO BOLTON RC, Calapaqui Teran AK, Santiago Almeida L, Paez D, et al
    Fibroblast Activation Protein Inhibitor (FAPI) PET in Sarcoma: An Update and Future Perspective.
    Semin Nucl Med. 2025 Jun 1:S0001-2998(25)00060.
    PubMed     Abstract available
    
    
    May 2025
98. MENA E, Lindenberg L, Herscovitch P, Sadowski SM, et al
    Advances in Endocrine Tumor PET Imaging Targeting CXCR4 and GLP-1.
    Semin Nucl Med. 2025 May 29:S0001-2998(25)00058.
    PubMed     Abstract available
    
    
    
99. THIENTUNYAKIT T, Muangpaisan W, Minoshima S
    (18)F-FDG PET for Dementia Evaluation: Co-pathologies, New Diseases, and Its Roles in the Era of Antiamyloid Treatment.
    Semin Nucl Med. 2025 May 29:S0001-2998(25)00057.
    PubMed     Abstract available
    
    
    
100. BENDER D
     New Radiopharmaceutical Tools in Imaging.
     Semin Nucl Med. 2025 May 26:S0001-2998(25)00059.
     PubMed     Abstract available
     
     
     
101. BARANSKA K, Niemas K, Pelka K, Kunikowska J, et al
     PET/CT in the Imaging of CNS Tumors.
     Semin Nucl Med. 2025 May 21:S0001-2998(25)00040.
     PubMed     Abstract available
     
     
     
102. LIN Z, Rasinski P, Nilsson T, Holstensson M, et al
     FAPI PET Versus FDG PET/CT in Gastrointestinal Cancers: An Overview.
     Semin Nucl Med. 2025 May 20:S0001-2998(25)00056.
     PubMed     Abstract available
     
     
     
103. BRINK A, Paez D, Estrada Lobato E, Delgado Bolton RC, et al
     New Targets for Imaging in Nuclear Medicine.
     Semin Nucl Med. 2025 May 6:S0001-2998(25)00039.
     PubMed     Abstract available
     
     
     
104. NERATTINI M, Abenavoli EM, Berti V
     PET/CT in Movement Disorders: Update.
     Semin Nucl Med. 2025 May 3:S0001-2998(25)00036.
     PubMed     Abstract available
     
     
     
105. CAIRNS J, Frood R, Patel C, Scarsbrook A, et al
     The Role of AI in Lymphoma: An Update.
     Semin Nucl Med. 2025;55:377-386.
     PubMed     Abstract available
     
     
     
106. EJAZ A, Naqvi AH, Perumalla HS, Bateman TM, et al
     Assessment of Myocardial Perfusion in Patients After CABG: An Update and Clinical Implications.
     Semin Nucl Med. 2025;55:460-469.
     PubMed     Abstract available
     
     
     April 2025
107. SPOHN SKB, Grosu AL
     Impact of PSMA PET on Radiation Oncology Planning.
     Semin Nucl Med. 2025 Apr 22:S0001-2998(25)00034.
     PubMed     Abstract available
     
     
     
108. VANDERLINDEN G, Vandenberghe R, Vandenbulcke M, Van Laere K, et al
     The Current Role of Tau PET Imaging in Neurodegeneration.
     Semin Nucl Med. 2025 Apr 21:S0001-2998(25)00031.
     PubMed     Abstract available
     
     
     
109. YANG F, Lei B, Zhou Z, Song TA, et al
     AI in SPECT Imaging: Opportunities and Challenges.
     Semin Nucl Med. 2025 Apr 3:S0001-2998(25)00033.
     PubMed     Abstract available
     
     
     March 2025
110. SAFARIAN A, Mirshahvalad SA, Farbod A, Nasrollahi H, et al
     Artificial intelligence for tumor [(18)F]FDG-PET imaging: Advancement and future trends-part I.
     Semin Nucl Med. 2025 Mar 29:S0001-2998(25)00032.
     PubMed     Abstract available
     
     
     
111. KIRIENKO M, Cavinato L, Sollini M
     Infection and Inflammation in Nuclear Medicine Imaging: The Role of Artificial Intelligence.
     Semin Nucl Med. 2025 Mar 21:S0001-2998(25)00021.
     PubMed     Abstract available
     
     
     
112. RICHLITZKI C, Manapov F, Holzgreve A, Rabe M, et al
     Advances of PET/CT in Target Delineation of Lung Cancer Before Radiation Therapy.
     Semin Nucl Med. 2025 Mar 9:S0001-2998(25)00022.
     PubMed     Abstract available
     
     
     
113. CANGUT B, Akinlusi R, Mohseny A, Ghesani N, et al
     Evolving Paradigms in Lung Cancer: Latest Trends in Diagnosis, Management, and Radiopharmaceuticals.
     Semin Nucl Med. 2025 Mar 6:S0001-2998(25)00013.
     PubMed     Abstract available
     
     
     
114. MIKKELSEN AFS, Thygesen J, Fledelius J
     Optimizing CT Imaging Parameters: Implications for Diagnostic Accuracy in Nuclear Medicine.
     Semin Nucl Med. 2025 Mar 6:S0001-2998(25)00015.
     PubMed     Abstract available
     
     
     
115. SAFARIAN A, Mirshahvalad SA, Nasrollahi H, Jung T, et al
     Impact of [(18)F]FDG PET/CT Radiomics and Artificial Intelligence in Clinical Decision Making in Lung Cancer: Its Current Role.
     Semin Nucl Med. 2025 Mar 5:S0001-2998(25)00014.
     PubMed     Abstract available
     
     
     
116. ALORFI F, Bomanji J, Bertoletti L, Fraioli F, et al
     PET/MRI in Non-Small Cell Lung Cancer (NSCLC).
     Semin Nucl Med. 2025 Mar 5:S0001-2998(25)00019.
     PubMed     Abstract available
     
     
     
117. DELEU AL, Shagera QA, Veldhuijzen van Zanten S, Flamen P, et al
     FAPI PET in the Management of Lung Tumors.
     Semin Nucl Med. 2025 Mar 3:S0001-2998(25)00018.
     PubMed     Abstract available
     
     
     February 2025
118. SATHEKGE C, Maes J, Maes A, Van de Wiele C, et al
     FDG PET/CT for Staging Lung Carcinoma: An Update.
     Semin Nucl Med. 2025 Feb 28:S0001-2998(25)00003.
     PubMed     Abstract available
     
     
     
119. AYENI A, Evbuomwan O, Vangu MW
     The Role of [(18)F]FDG PET/CT in Monitoring of Therapy Response in Lung Cancer.
     Semin Nucl Med. 2025 Feb 27:S0001-2998(25)00010.
     PubMed     Abstract available
     
     
     
120. BADARNA M, Keidar Z, Arnon-Sheleg E
     Current and Future Perspective of PET/CT in Response Assessment of Malignant Pleural Mesothelioma.
     Semin Nucl Med. 2025 Feb 27:S0001-2998(25)00009.
     PubMed     Abstract available
     
     
     
121. VINJAMURI S, Pant V
     Demystifying the Role of Immuno PET-CT in Non-Small Cell Lung Cancer: Clinical Value and Research Trends.
     Semin Nucl Med. 2025 Feb 26:S0001-2998(25)00011.
     PubMed     Abstract available
     
     
     
122. CURRIE GM, Rohren EM
     Potential of Technetium and Rhenium Theranostics.
     Semin Nucl Med. 2025 Feb 24:S0001-2998(25)00006.
     PubMed     Abstract available
     
     
     
123. LOPES L, Lopez-Montes A, Chen Y, Koller P, et al
     The Evolution of Artificial Intelligence in Nuclear Medicine.
     Semin Nucl Med. 2025 Feb 10:S0001-2998(25)00005.
     PubMed     Abstract available
     
     
     January 2025
124. LIU J, Sandhu K, Woon DTS, Perera M, et al
     The Value of Artificial Intelligence in Prostate-Specific Membrane Antigen Positron Emission Tomography: An Update.
     Semin Nucl Med. 2025 Jan 31:S0001-2998(24)00120.
     PubMed     Abstract available
     
     
     
125. MOHSENINIA N, Eisazadeh R, Mirshahvalad SA, Zamani-Siahkali N, et al
     Diagnostic Value of Gastrin-Releasing Peptide Receptor-Targeted PET Imaging in Oncology: A Systematic Review.
     Semin Nucl Med. 2025 Jan 23:S0001-2998(25)00001.
     PubMed     Abstract available
     
     
     December 2024
126. SACHPEKIDIS C, Goldschmidt H, Edenbrandt L, Dimitrakopoulou-Strauss A, et al
     Radiomics and Artificial Intelligence Landscape for [(18)F]FDG PET/CT in Multiple Myeloma.
     Semin Nucl Med. 2024 Dec 13:S0001-2998(24)00111.
     PubMed     Abstract available
     
     
     November 2024
127. RATHOD N, Jutidamrongphan W, Bosbach WA, Chen Y, et al
     Total Body PET/CT: Clinical Value and Future Aspects of Quantification in Static and Dynamic Imaging.
     Semin Nucl Med. 2024 Nov 29:S0001-2998(24)00110.
     PubMed     Abstract available
     
     
     
128. ZOGHI S, Mingels C, Badawi RD, Spencer BA, et al
     Role of Total Body PET/CT in Inflammatory Disorders.
     Semin Nucl Med. 2024 Nov 21:S0001-2998(24)00107.
     PubMed     Abstract available
     
     
     
129. HAWK KE, Currie GM
     Artificial Intelligence and Workforce Diversity in Nuclear Medicine.
     Semin Nucl Med. 2024 Nov 19:S0001-2998(24)00090.
     PubMed     Abstract available
     
     
     
130. GERKE O, Naghavi-Behzad M, Nygaard ST, Sigaroudi VR, et al
     Diagnosing Bone Metastases in Breast Cancer: A Systematic Review and Network Meta-Analysis on Diagnostic Test Accuracy Studies of 2-[(18)F]FDG-PET/CT, (18)F-NaF-PET/CT, MRI, Contrast-Enhanced CT, and Bone Scintigraphy.
     Semin Nucl Med. 2024 Nov 14:S0001-2998(24)00093.
     PubMed     Abstract available
     
     
     
131. DIAS AH, Andersen KF, Fosbol MO, Gormsen LC, et al
     Long Axial Field-of-View PET/CT: New Opportunities for Pediatric Imaging.
     Semin Nucl Med. 2024 Nov 13:S0001-2998(24)00092.
     PubMed     Abstract available
     
     
     
132. GODINEZ F, Mingels C, Bayerlein R, Mehadji B, et al
     Total Body PET/CT: Future Aspects.
     Semin Nucl Med. 2024 Nov 13:S0001-2998(24)00096.
     PubMed     Abstract available
     
     
     
133. MARTINEZ-LUCIO TS, Mendoza-Ibanez OI, Liu W, Mostafapour S, et al
     Long Axial Field of View PET/CT: Technical Aspects in Cardiovascular Diseases.
     Semin Nucl Med. 2024 Nov 12:S0001-2998(24)00094.
     PubMed     Abstract available
     
     
     
134. YANG N, Guo XY, Ding J, Wang F, et al
     Copper-64 Based PET-Radiopharmaceuticals: Ways to Clinical Translational.
     Semin Nucl Med. 2024 Nov 8:S0001-2998(24)00086.
     PubMed     Abstract available
     
     
     
135. NANNI C, Farolfi A, Castellucci P, Fanti S, et al
     Total Body Positron Emission Tomography/Computed Tomography: Current Status in Oncology.
     Semin Nucl Med. 2024 Nov 7:S0001-2998(24)00091.
     PubMed     Abstract available
     
     
     
136. DEV ID, Puranik AD, Singh B, Prasad V, et al
     Current and Future Perspectives of PDL1 PET and SPECT Imaging.
     Semin Nucl Med. 2024 Nov 6:S0001-2998(24)00084.
     PubMed     Abstract available
     
     
     
137. LIN Y, Gao H, Zheng J, Al-Ibraheem A, et al
     Clinical Explorations of [(68)Ga] Ga-FAPI-04 and [(18)F] FDG Dual-Tracer Total-body PET/CT and PET/MR Imaging.
     Semin Nucl Med. 2024 Nov 2:S0001-2998(24)00085.
     PubMed     Abstract available
     
     
     
138. MENA E, Lindenberg L, Choyke PL
     Update on PSMA-based Prostate Cancer Imaging.
     Semin Nucl Med. 2024;54:941-950.
     PubMed     Abstract available
     
     
     
139. O'BRIEN SR, Edmonds CE, Ward RE, Taunk NK, et al
     Update on (18)F-Fluoroestradiol.
     Semin Nucl Med. 2024;54:812-826.
     PubMed     Abstract available
     
     
     October 2024
140. CUMBERS GA, Harvey-Latham ED, Kassiou M, Werry EL, et al
     Emerging TSPO-PET Radiotracers for Imaging Neuroinflammation: A Critical Analysis.
     Semin Nucl Med. 2024 Oct 29:S0001-2998(24)00082.
     PubMed     Abstract available
     
     
     
141. DUVENHAGE J, Kahts M, Summers B, Zeevaart JR, et al
     Highlighting New Research Trends on Zirconium-89 Radiopharmaceuticals Beyond Antibodies.
     Semin Nucl Med. 2024 Oct 26:S0001-2998(24)00088.
     PubMed     Abstract available
     
     
     
142. NOGUEIRA-LIMA E, Alves T, Etchebehere E
     (18)F-Fluoride PET/CT-Updates.
     Semin Nucl Med. 2024 Oct 10:S0001-2998(24)00083.
     PubMed     Abstract available
     
     
     
143. MENG X, Kong X, Wu R, Yang Z, et al
     Total Body PET/CT: A Role in Drug Development?
     Semin Nucl Med. 2024 Oct 9:S0001-2998(24)00081.
     PubMed     Abstract available
     
     
     
144. STORMEZAND GN, de Meyer E, Koopmans KP, Brouwers AH, et al
     Update on the Role of [(18)F]FDOPA PET/CT.
     Semin Nucl Med. 2024 Oct 8:S0001-2998(24)00080.
     PubMed     Abstract available
     
     
     
145. AL-IBRAHEEM A, Abdlkadir AS, Shi H, Abdel-Razeq H, et al
     PET/CT Assessment of Estrogen Receptor positivity for Breast Cancer using [(68)Ga]Ga-RM2 Bombesin Receptor Antagonist: A Systematic Review and Meta-Analysis.
     Semin Nucl Med. 2024 Oct 5:S0001-2998(24)00079.
     PubMed     Abstract available
     
     
     
146. ZHANG Q, Huang Z, Jin Y, Li W, et al
     Total-Body PET/CT: A Role of Artificial Intelligence?
     Semin Nucl Med. 2024 Oct 4:S0001-2998(24)00078.
     PubMed     Abstract available
     
     
     September 2024
147. MINGELS C, Chung KJ, Pantel AR, Rominger A, et al
     Total-Body PET/CT: Challenges and Opportunities.
     Semin Nucl Med. 2024 Sep 27:S0001-2998(24)00076.
     PubMed     Abstract available
     
     
     
148. NOSKOVICOVA L, Balogova S, Aveline C, Tassart M, et al
     (18)F-Fluorocholine-Positron Emission Tomography/Computerized Tomography (FCH PET/CT) Imaging for Detecting Abnormal Parathyroid Glands: Indication, Practice, Interpretation and Diagnostic Performance.
     Semin Nucl Med. 2024 Sep 20:S0001-2998(24)00075.
     PubMed     Abstract available
     
     
     
149. HICKS RJ, Ware RE, Callahan J
     Total-Body PET/CT: Pros and Cons.
     Semin Nucl Med. 2024 Sep 16:S0001-2998(24)00065.
     PubMed     Abstract available
     
     
     
150. NAYFEH M, Sayed A, Alwan M, Alfawara M, et al
     Hybrid Imaging: Calcium Score and Myocardial Perfusion Imaging.
     Semin Nucl Med. 2024;54:638-647.
     PubMed     Abstract available
     
     
     
151. CLERC OF, Vijayakumar S, Dorbala S
     Radionuclide Imaging of Cardiac Amyloidosis: An Update and Future Aspects.
     Semin Nucl Med. 2024;54:717-732.
     PubMed     Abstract available
     
     
     
152. MILLER RJH, Slomka PJ
     Artificial Intelligence in Nuclear Cardiology: An Update and Future Trends.
     Semin Nucl Med. 2024;54:648-657.
     PubMed     Abstract available
     
     
     August 2024
153. COURAULT P, Zimmer L, Lancelot S
     Toward Functional PET Imaging of the Spinal Cord.
     Semin Nucl Med. 2024 Aug 23:S0001-2998(24)00066.
     PubMed     Abstract available
     
     
     July 2024
154. WAHL RL, Kahl B
     The Rebirth of Radioimmunotherapy of Non-Hodgkin Lymphoma: The Phoenix of Nuclear Medicine?
     Semin Nucl Med. 2024 Jul 16:S0001-2998(24)00055.
     PubMed     Abstract available
     
     
     
155. KLEYNHANS J, Ebenhan T, Sathekge MM
     Expanding Role for Gallium-68 PET Imaging in Oncology.
     Semin Nucl Med. 2024 Jul 3:S0001-2998(24)00054.
     PubMed     Abstract available
     
     
     
156. SATHEKGE MM, Bouchelouche K
     Letter from the Editors.
     Semin Nucl Med. 2024;54:457-459.
     PubMed    
     
     
     June 2024
157. KATAL S, Patel P, Lee J, Taubman K, et al
     Total Body PET/CT: A Role in Musculoskeletal Diseases.
     Semin Nucl Med. 2024 Jun 28:S0001-2998(24)00049.
     PubMed     Abstract available
     
     
     
158. MAHAJAN S, Gavane S, Pandit-Taskar N
     Targeted Radiopharmaceutical Therapy for Bone Metastases.
     Semin Nucl Med. 2024 Jun 26:S0001-2998(24)00047.
     PubMed     Abstract available
     
     
     
159. DULLEA A, O'Sullivan L, O'Brien KK, Carrigan M, et al
     Diagnostic Accuracy of (18)F-Prostate Specific Membrane Antigen (PSMA) PET/CT Radiotracers in Staging and Restaging of Patients With High-Risk Prostate Cancer or Biochemical Recurrence: An Overview of Reviews.
     Semin Nucl Med. 2024 Jun 20:S0001-2998(24)00044.
     PubMed     Abstract available
     
     
     
160. KAZIMIERCZYK R, Kaminski KA, Nekolla SG
     Cardiac PET/MRI: Recent Developments and Future Aspects.
     Semin Nucl Med. 2024 Jun 8:S0001-2998(24)00048.
     PubMed     Abstract available
     
     
     
161. DIMITRAKOPOULOU-STRAUSS A, Pan L, Sachpekidis C
     Total Body PET-CT Protocols in Oncology.
     Semin Nucl Med. 2024 Jun 7:S0001-2998(24)00050.
     PubMed     Abstract available
     
     
     
162. CURRIE GM, Hawk KE, Rohren EM
     Generative Artificial Intelligence Biases, Limitations and Risks in Nuclear Medicine: An Argument for Appropriate Use Framework and Recommendations.
     Semin Nucl Med. 2024 Jun 7:S0001-2998(24)00046.
     PubMed     Abstract available
     
     
     
163. SACHPEKIDIS C, Dimitrakopoulou-Strauss A
     Long Axial Field-of-View (LAFOV) PET/CT in Prostate Cancer.
     Semin Nucl Med. 2024 Jun 1:S0001-2998(24)00045.
     PubMed     Abstract available
     
     
     May 2024
164. BOUCHELOUCHE K, Sathekge MM
     Letter from the Editors.
     Semin Nucl Med. 2024;54:311-312.
     PubMed    
     
     
     
165. HABERL C, Crean AM, Zelt JGE, Redpath CJ, et al
     Role of Nuclear Imaging in Cardiac Stereotactic Body Radiotherapy for Ablation of Ventricular Tachycardia.
     Semin Nucl Med. 2024;54:427-437.
     PubMed     Abstract available
     
     
     April 2024
166. PAEZ D, Giammarile F, Brink A, Garcia-Perez O, et al
     The Role of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) in the Diagnosis and Evaluation of Spondylodiscitis.
     Semin Nucl Med. 2024 Apr 29:S0001-2998(24)00032.
     PubMed     Abstract available
     
     
     
167. GUJA KE, Behr G, Bedmutha A, Kuhn M, et al
     Molecular Imaging with PET-CT and PET-MRI in Pediatric Musculoskeletal Diseases.
     Semin Nucl Med. 2024 Apr 29:S0001-2998(24)00030.
     PubMed     Abstract available
     
     
     March 2024
168. VAN DER GEEST KSM, Gheysens O, Gormsen LC, Glaudemans AWJM, et al
     Advances in PET Imaging of Large Vessel Vasculitis: An Update and Future Trends.
     Semin Nucl Med. 2024 Mar 26:S0001-2998(24)00026.
     PubMed     Abstract available
     
     
     
169. HIGUCHI T, Serfling SE, Leistner DM, Speer T, et al
     FAPI-PET in Cardiovascular Disease.
     Semin Nucl Med. 2024 Mar 21:S0001-2998(24)00023.
     PubMed     Abstract available
     
     
     
170. GUJA KE, Ganjoo KN, Iagaru A
     Molecular Imaging in Soft-tissue Sarcoma: Evolving Role of FDG PET.
     Semin Nucl Med. 2024 Mar 2:S0001-2998(24)00012.
     PubMed     Abstract available
     
     
     
171. EKMEKCIOGLU O, Albert NL, Heinrich K, Tolboom N, et al
     Neurological Disorders and Women's Health: Contribution of Molecular Neuroimaging Techniques.
     Semin Nucl Med. 2024;54:237-246.
     PubMed     Abstract available
     
     
     
172. EVANGELISTA L, Israel O
     Letter From the Guest Editors.
     Semin Nucl Med. 2024;54:181-182.
     PubMed    
     
     
     
173. FILIPPI L, Camedda R, Frantellizzi V, Urbano N, et al
     Functional Imaging in Musculoskeletal Disorders in Menopause.
     Semin Nucl Med. 2024;54:206-218.
     PubMed     Abstract available
     
     
     February 2024
174. KHALATBARI H, Shulkin BL, Parisi MT
     PET/CT and PET/MR in Soft Tissue Sarcoma: An Update.
     Semin Nucl Med. 2024 Feb 28:S0001-2998(24)00005.
     PubMed     Abstract available
     
     
     
175. ULANER GA, Vaz SC
     Women's Health Update: Growing Role of PET for Patients with Breast Cancer.
     Semin Nucl Med. 2024 Feb 16:S0001-2998(24)00006.
     PubMed     Abstract available
     
     
     
176. GIAMMARILE F, Knoll P, Paez D, Estrada Lobato E, et al
     Fibroblast Activation Protein Inhibitor (FAPI) PET Imaging in Sarcomas: A New Frontier in Nuclear Medicine.
     Semin Nucl Med. 2024 Feb 15:S0001-2998(24)00001.
     PubMed     Abstract available
     
     
     
177. KHESSIB T, Jha P, Davidzon GA, Iagaru A, et al
     Nuclear Medicine and Molecular Imaging Applications in Gynecologic Malignancies: A Comprehensive Review.
     Semin Nucl Med. 2024 Feb 10:S0001-2998(24)00003.
     PubMed     Abstract available
     
     
     
178. EISAZADEH R, Shahbazi-Akbari M, Mirshahvalad SA, Pirich C, et al
     Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [(18)F]F-FDG Tracers Part II. [(18)F]F-FLT, [(18)F]F-FET, [(11)C]C-MET and Other Less-Commonly Used Radiotracers.
     Semin Nucl Med. 2024 Feb 7:S0001-2998(24)00002.
     PubMed     Abstract available
     
     
     January 2024
179. EVANGELISTA L, Guglielmo P, Pietrzak A, Lazar AM, et al
     The Future Direction of Women in Nuclear Medicine and Nuclear Medicine in Women's Health.
     Semin Nucl Med. 2024 Jan 12:S0001-2998(23)00105.
     PubMed     Abstract available
     
     
     
180. ZAMANI-SIAHKALI N, Mirshahvalad SA, Farbod A, Divband G, et al
     SPECT/CT, PET/CT, and PET/MRI for Response Assessment of Bone Metastases.
     Semin Nucl Med. 2024 Jan 2:S0001-2998(23)00093.
     PubMed     Abstract available
     
     
     December 2023
181. BENTESTUEN M, Nalliah S, Stolberg MMK, Zacho HD, et al
     How to Perform FAPI PET? An Expedited Systematic Review Providing a Recommendation for FAPI PET Imaging With Different FAPI Tracers.
     Semin Nucl Med. 2023 Dec 4:S0001-2998(23)00092.
     PubMed     Abstract available
     
     
     
182. TELLI T, Desaulniers M, Pyka T, Caobelli F, et al
     What Role Does PET/MRI Play in Musculoskeletal Disorders?
     Semin Nucl Med. 2023 Dec 2:S0001-2998(23)00091.
     PubMed     Abstract available
     
     
     November 2023
183. GHEYSENS O, de Ponfilly MP, Nocturne G, Seror R, et al
     [(18)F]FDG-PET/CT in Polymyalgia Rheumatica: An Update and Future Aspects.
     Semin Nucl Med. 2023 Nov 28:S0001-2998(23)00083.
     PubMed     Abstract available
     
     
     
184. MOKOALA KMG, Ndlovu H, Lawal I, Sathekge MM, et al
     PET/CT and SPECT/CT for Infection in Joints and Bones: An Overview and Future Directions.
     Semin Nucl Med. 2023 Nov 27:S0001-2998(23)00087.
     PubMed     Abstract available
     
     
     
185. BRINK A, Israel O, Nadel H, Arevalo-Pardo M, et al
     Towards a More Inclusive Future: A Comprehensive Assessment of Gender Diversity in Nuclear Medicine Education, Training and Workforce.
     Semin Nucl Med. 2023 Nov 18:S0001-2998(23)00086.
     PubMed     Abstract available
     
     
     
186. VOTER AF, Werner RA, Savas H, Gafita A, et al
     A Practical Guide to the Pearls and Pitfalls of PSMA PET Imaging.
     Semin Nucl Med. 2023 Nov 16:S0001-2998(23)00088.
     PubMed     Abstract available
     
     
     
187. BESSON FL, Nocturne G, Noel N, Gheysens O, et al
     PET/CT in Inflammatory and Auto-immune Disorders: Focus on Several Key Molecular Concepts, FDG, and Radiolabeled Probe Perspectives.
     Semin Nucl Med. 2023 Nov 14:S0001-2998(23)00084.
     PubMed     Abstract available
     
     
     
188. CARACCIOLO M, Castello A, Lopci E
     PSMA PET/CT Versus mpMRI for the Detection of Clinically Significant Prostate Cancer: An Updated Overview.
     Semin Nucl Med. 2023 Nov 9:S0001-2998(23)00082.
     PubMed     Abstract available
     
     
     
189. GIUBBINI R, Paghera B, Dondi M, Estrada Lobato E, et al
     Critical Appraisal of the Current Role of Myocardial Perfusion Imaging in the Management of Acute Chest Pain.
     Semin Nucl Med. 2023;53:733-742.
     PubMed     Abstract available
     
     
     
190. LOW CS, Rao N
     Imaging of Gastrointestinal Bleeding: An Update.
     Semin Nucl Med. 2023;53:766-776.
     PubMed     Abstract available
     
     
     
191. SIRAJ QH
     Functional Imaging of Testicular Torsion.
     Semin Nucl Med. 2023;53:797-808.
     PubMed     Abstract available
     
     
     
192. LE ROUX PY, Le Pennec R, Salaun PY, Zuckier LS, et al
     Scintigraphic Diagnosis of Acute Pulmonary Embolism: From Basics to Best Practices.
     Semin Nucl Med. 2023;53:743-751.
     PubMed     Abstract available
     
     
     
193. JABBARPOUR A, Ghassel S, Lang J, Leung E, et al
     The Past, Present, and Future Role of Artificial Intelligence in Ventilation/Perfusion Scintigraphy: A Systematic Review.
     Semin Nucl Med. 2023;53:752-765.
     PubMed     Abstract available
     
     
     
194. LINDENBERG L, Ahlman M, Lin F, Mena E, et al
     Advances in PET Imaging of the CXCR4 Receptor: [(68)Ga]Ga-PentixaFor.
     Semin Nucl Med. 2023 Nov 1:S0001-2998(23)00080.
     PubMed     Abstract available
     
     
     September 2023
195. MIRSHAHVALAD SA, Eisazadeh R, Shahbazi-Akbari M, Pirich C, et al
     Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [(18)F]F-FDG Tracers - Part I. PSMA, Choline, and DOTA Radiotracers.
     Semin Nucl Med. 2023 Sep 24:S0001-2998(23)00073.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum